AbbVie cuts ties with Google-backed longevity agency Calico, lays off scientists

Damian Garde is a reporter at giant, dwell and have journalism, overlaying the worldwide drug {industry} and contributing to STAT’s industry-leading occasions.

AbbVie is ending a decade-long partnership with Calico Life Sciences, an Alphabet-funded biotech firm centered on getting old analysis, and shedding chemists engaged on discovering new medication.

The strikes, detailed in inner emails despatched Tuesday and seen by STAT, come because the pharmaceutical big is shifting away from small-molecule medication, which embody capsules, and investing extra in injectable therapies and sophisticated genetic medicines. 

AbbVie didn’t instantly reply to a request for remark Wednesday.

STAT+ Unique Story

Have already got an account? Log in

This text is unique to STAT+ subscribers

Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.

Have already got an account? Log in

Particular person plans

Group plans

View All Plans